SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-010313
Filing Date
2021-02-12
Accepted
2021-02-12 17:39:13
Documents
2
Period of Report
2021-02-10

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2151
2 POA DOCUMENT poa.txt EX-24.3_962707 3372
  Complete submission text file 0001209191-21-010313.txt   6998
Mailing Address C/O AXOVANT SCIENCES, INC. 320 WEST 37TH STREET, 5TH FLOOR NEW YORK NY 10018
Business Address
FALBERG KATHRYN E (Reporting) CIK: 0001206977 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39351 | Film No.: 21630130

Mailing Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103
Business Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103 (415) 754-3517
Nuvation Bio Inc. (Issuer) CIK: 0001811063 (see all company filings)

IRS No.: 850862255 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations